NewAmsterdam Pharma Company N.V.

NAMS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$771,743$340,450$467,728$60,380
Short-Term Investments$62,447$0$0$0
Receivables$21,305$1,881$0$0
Inventory$0$0$0$0
Other Curr. Assets$0$0$2,070$4,879
Total Curr. Assets$863,413$346,791$477,979$66,956
Property Plant & Equip (Net)$673$101$154$216
Goodwill$0$0$0$0
Intangibles$534$170$208$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$35$156$817
Total NC Assets$1,207$306$518$1,033
Other Assets$0$0$0$0
Total Assets$864,620$347,097$478,497$67,988
Liabilities
Payables$4,744$16,923$11,853$7,074
Short-Term Debt$246$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$6,008$8,942$0$0
Other Curr. Liab.$91,033$15,958$18,021$0
Total Curr. Liab.$106,918$49,897$36,057$11,236
LT Debt$0$0$0$0
Deferred Rev, NC$0$1,019$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$7,788$12,314$0
Total NC Liab.$202$8,807$12,374$126
Other Liabilities$0$0$0$0
Cap. Leases$448$60$126$187
Total Liabilities$107,120$58,704$48,431$11,362
Equity
Pref Stock$0$0$0$0
Common Stock$13,444$10,173$10,055$129
Retained Earnings$0-$316,973-$140,036-$39,436
AOCI$4,467$4,422$4,422$672
Other Equity$739,589$0$0$0
Total Equity$757,500$288,393$430,066$56,626
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$864,620$347,097$478,497$67,988
Net Debt-$771,497-$340,450-$467,728-$60,380
NewAmsterdam Pharma Company N.V. (NAMS) Financial Statements & Key Stats | AlphaPilot